Abiomed Taps GE Exec Minogue For CEO Slot, Adding Marketing Expertise
This article was originally published in The Gray Sheet
Executive Summary
Newly appointed Abiomed President & CEO Michael Minogue's goals for 2004 include corporate profitability and a full rollout of the AB5000 Circulatory Support System
You may also be interested in...
Abiomed Paves Bridge-To-Recovery Market On Road To Destination Therapy
Abiomed is refocusing its ventricular-assist device (VAD) sales efforts on open-heart surgery instead of transplant centers to climb out of an unprofitable quarter and sequential loss of revenue
Abiomed Paves Bridge-To-Recovery Market On Road To Destination Therapy
Abiomed is refocusing its ventricular-assist device (VAD) sales efforts on open-heart surgery instead of transplant centers to climb out of an unprofitable quarter and sequential loss of revenue
Abiomed attracts more GE alumni
AbioCor totally implantable artificial heart manufacturer signs three new executives June 16: VP-Operations Javier Jimenez, VP-Corporate Marketing Raymond Kelley and Senior-VP Global Sales, Applications and Service Christopher Macdonald. Jimenez, Kelley and Macdonald all come to Abiomed from GE, where they most recently served as GE Healthcare IT Americas director of commercial operations, a magnetic resonance sales specialist and a U.S. cardiology zone manager, respectively. Abiomed President & CEO Michael Minogue, who assumed the firm's top management spot in April, also came from GE (1"The Gray Sheet" April 12, 2004, p. 20)...